Taytulla Birth Control Recall & Lawsuits
Women who are taking Taytulla birth control pills need to carefully examine the packages. According to a recent announcement by manufacturer Allergan, some of the products may have been packaged incorrectly, placing the placebo or inactive “blank” pills, out of order.
On May 29, 2018, Allergan implemented a voluntary recall of one lot because of this issue. About 170,000 packs of Taytulla birth control pills are subject to this recall. If a woman takes the “blank pills” early because of a packaging error, her risk of becoming pregnant increases.
The recall only covers those pills given as “free samples” by a doctor’s office. The company plans to send notification letters out to doctors and suggested that patients who received Taytulla birth control pills from their doctors talk to them about the issue.
The pills in this particular lot have been on the market since August 2017. If you took the pills and became pregnant unintentionally, contact the Taytulla lawyers at Chaffin Luhana today. We are currently investigating cases in which Taytulla birth control did not work as expected.
Allergan Recalls 170,000 Units of Taytulla Birth Control
On May 19, 2018, Allergan issued a press release notifying the public that it was recalling about 170,000 packages of Taytulla. The recall was issued after the manufacturer received a doctor reported that the four placebo inactive capsules were placed out of order in a sample pack of the pills received from the company. Specifically, the four placebo pills were placed at the beginning of the packet rather than at the end.
“As a result of this packaging error,” Allergan stated, “oral contraceptive capsules, that are taken out of sequence, may place the user at risk for contraceptive failure and unintended pregnancy.” The manufacturer also noted that users may not be aware that they’re taking inactive pills at the wrong time of the month, particularly if they are new users who haven’t been on birth control therapy before.
Allergan advised consumers who used a Taytulla sample pack with lot number 5620706 to contact their physicians. The products have an expiration date of May 2019 and were distributed nationwide to healthcare providers between August 2017 and May 2018.
So far, the recall affects only those sample packs received at the doctor’s office. It doesn’t affect packs purchased from a pharmacy.
Allergan is notifying doctors via a recall letter and is arranging for the return of all recalled sample packs products. Consumers who have one of these packs should talk to their doctors about arranging a return. They can also call Allergan at 800-678-1605 between 8:00 a.m. and 8:00 p.m. EST Monday through Friday.
FDA Supports Nationwide Taytulla Birth Control Recall
The FDA also released an announcement on May 29, 2018, concerning the recall. They noted that the four placebo capsules had been reported to be out of order on one of the packets and that such an error could result in contraceptive failure.
They also urged healthcare professionals and patients to report any adverse events or side effects related to the use of Taytulla to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program online at the MedWatch reporting site, by downloading a form, or by calling 1-800-332-1088 to request a reporting form.
What is Taytulla?
Taytulla is an oral contraceptive that contains the hormones progestin and estrogen. It comes in a regiment of 24 pink soft gelatin capsules that carry the active ingredients, and four maroon soft gelatin capsules that contain no active medication. It’s considered a “low-dose” birth control pill as it contains only 20 micrograms of daily estrogen, and was found to be 96 percent effective in pregnancy prevention when taken as directed.
The hormones in Taytulla (and in other birth control pills) prevent pregnancy by helping to inhibit the body’s natural hormones. They stop ovulation—the release of the egg into the uterus—so the egg cannot be fertilized.
The hormones also help stabilize hormone levels and prevent the normal “estrogen-peak” which usually increases in the middle of a woman’s monthly cycle. As a result, the pituitary gland fails to release other hormones that stimulate the release of an egg.
Birth control pills also help to make the uterine lining less welcoming to a fertilized egg and cause the cervical mucus to thicken, which makes it harder for sperm to make contact with an egg.
A “combination” pill like Taytulla contains two hormones (estrogen and progestin), whereas some contain only progestin. The combination pills have been found to be more effective, but women who cannot tolerate the excess estrogen may prefer the progestin-only pills.
Like most birth control pill packages, Taytulla contains mostly active pills, and then some inactive pills. The extra pills are provided for a couple reasons:
- To provide a pill for every day of the month, to help women sustain the habit of taking a daily dose.
- To provide a break from the hormones, to trigger monthly bleeding that mimics the menstrual period.
As long as the inactive pills are taken at the end of the cycle, they will stimulate menstrual bleeding and the woman will remain protected from pregnancy. If the inactive pills are taken out of order, however, they will not have the same effect, and the women may experience an unintended conception.
Types of Injuries Associated with Taytulla
Women who take the Taytulla birth control pills out of order are at risk for:
- Breakthrough bleeding
- Unintended pregnancy
Filing a Taytulla Birth Control Lawsuit
If you took Taytulla birth control pills and you still got pregnant, you may be eligible to file a Taytulla lawsuit to recover damages. Chaffin Luhana is currently investigating these cases and invites you to call today at 1-888-316-2311 or complete our free consultation form.